Inhaled chemotherapy in lung cancer: future concept of nanomedicine

Zarogoulidis, Paul; Chatzaki, Ekaterini; Porpodis, Konstantinos; Domvri, Kalliopi; Hohenforst-Schmidt, Wolfgang; Goldberg, Eugene P.; Karamanos, Nikos; Zarogoulidis, Konstantinos
January 2012
International Journal of Nanomedicine;2012, Vol. 7, p1551
Academic Journal
No abstract available.


Related Articles

  • Lung Cancer. Parmet, Sharon; Lymn, Cassio; Glass, Richard M. // JAMA: Journal of the American Medical Association;8/24/2005, Vol. 294 Issue 8, p990 

    Presents information on lung cancer and how it forms. Factors that contribute to lung cancer, such as smoking or inhaling second-hand smoke; Symptoms; How it is diagnosed; Treatment methods, including surgery and chemotherapy.

  • Theranostic nanomedicine for cancer detection and treatment. Zhen Fan; Fu, Peter P.; Hongtao Yu; Ray, Paresh C. // Journal of Food & Drug Analysis;Mar2014, Vol. 22 Issue 1, p3 

    Cancer is the second leading cause of death in the USA according to the American Cancer Society. In the past 5 years, "theranostic nanomedicine", for both therapeutics and imaging, has shown to be "the right drug for the right patient at the right moment" to manage deadly cancers. This review...

  • Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery. Willis, Lauren; Hayes, Don; Mansour, Heidi // Lung;Jun2012, Vol. 190 Issue 3, p251 

    Therapeutic liposomal powders (i.e., lipospheres and proliposomes) for dry powder inhalation aerosol delivery, formulated with phospholipids similar to endogenous lung surfactant, offer unique opportunities in pulmonary nanomedicine while offering controlled release and enhanced stability. Many...

  • Inhale lung chemo to limit organ damage.  // New Scientist;5/29/2010, Vol. 206 Issue 2762, p18 

    The article discusses a report in a 2010 issue of "Proceedings of the National Academy of Science," by researchers at Rutgers University in New Jersey, investigating the effectiveness of packaging lung cancer drugs in inhalable bubbles for use in chemotherapy.

  • Aerosolized Chemotherapy? Inhalation Therapy Gains Ground. McCann, Jean // JNCI: Journal of the National Cancer Institute;4/17/2002, Vol. 94 Issue 8, p556 

    Reports on the 12th International Congress on Anti-Cancer Treatment held in Paris, France. Development of ways to deliver chemotherapy drugs directly into the lungs; Information on treating lung metastases from renal cell carcinoma with interleukin 2; Administration of clinical trials of the...

  • Nano-Oncology: Clinical Application for Cancer Therapy and Future Perspectives. Riggio, Cristina; Pagni, Eleonora; Raffa, Vittoria; Cuschieri, Alfred // Journal of Nanomaterials;2011, p1 

    Nano-oncology, the application of Nanomedicine to cancer diagnosis and treatment, has the potential to transform clinical oncology by enhancing the efficacy of cancer chemotherapy for a wide spectrum of invasive cancers. It achieves this by enabling novel drug delivery systems which target the...

  • Drug development for intraperitoneal chemotherapy against peritoneal carcinomatosis from gastrointestinal cancer. Emoto, Shigenobu; Sunami, Eiji; Yamaguchi, Hironori; Ishihara, Soichiro; Kitayama, Joji; Watanabe, Toshiaki // Surgery Today;Dec2014, Vol. 44 Issue 12, p2209 

    Intraperitoneal (IP) chemotherapy for peritoneal carcinomatosis (PC) from gastrointestinal cancer has been investigated and applied clinically for several decades. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy have been considered to be the optimal treatment options for...

  • Black Lung Disease.  // World Book Science Dataset;1/1/2009, p1 

    Black Lung Disease, or Coal Miner's Disease, a disease of the lungs caused by the inhalation of carbonates, especially coal dust. It is an occupational disease, occurring mainly in coal miners. Small, fine particles tend to collect in the lungs, causing the formation of fibrous nodules. As the...

  • Nanotechnology-Based Detection and Targeted Therapy in Cancer: Nano-Bio Paradigms and Applications. Mousa, Shaker A.; Bharali, Dhruba J. // Cancers;2011, Vol. 3 Issue 3, p2888 

    The application of nanotechnology to biomedicine, particularly in cancer diagnosis and treatment, promises to have a profound impact on healthcare. The exploitation of the unique properties of nano-sized particles for cancer therapeutics is most popularly known as nanomedicine. The goals of this...

  • Clinical translational challenges in nanomedicine. Sengupta, Shiladitya // MRS Bulletin;Mar2014, Vol. 39 Issue 3, p259 

    After a decade of active research, pressure is mounting for clinical translation of nanomedicines. However, to enable success in the clinic, it is important to understand the factors that can pose challenges. For example, reduction in adverse effects alone might not be enough of a driver today...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics